Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia

C Dai Phung, TH Tran, HT Nguyen, JH Jeong… - Journal of Controlled …, 2020 - Elsevier
Hypoxia is a common feature of the tumor microenvironment, which is characterized by
tissue oxygen deficiency due to an aggressive proliferation of cancer cells. Hypoxia …

[HTML][HTML] Serum albumin for magnetic nanoparticles coating

AS Chubarov - Magnetochemistry, 2022 - mdpi.com
Magnetic nanoparticles (MNPs) have great potential in biochemistry and medical science. In
particular, iron oxide nanoparticles have demonstrated a promising effect in various …

Preparation of Drug‐Loaded Albumin Nanoparticles and Its Application in Cancer Therapy

R Meng, H Zhu, Z Wang, S Hao… - Journal of …, 2022 - Wiley Online Library
Albumin is derived from plasma and it is the most abundant protein in plasma, which is an
ideal material for the preparation of nanoparticles because of its good biocompatibility …

Targeted delivery of albumin nanoparticles for breast cancer: A review

SS Kunde, S Wairkar - Colloids and Surfaces B: Biointerfaces, 2022 - Elsevier
Breast cancer has been identified as one of the most common cancers diagnosed in women.
Various nanotechnology platforms offering unique features are considered in breast cancer …

[HTML][HTML] Human serum albumin based nanodrug delivery systems: recent advances and future perspective

C Li, D Zhang, Y Pan, B Chen - Polymers, 2023 - mdpi.com
With the success of several clinical trials of products based on human serum albumin (HSA)
and the rapid development of nanotechnology, HSA-based nanodrug delivery systems …

Organoids technology for advancing the clinical translation of cancer nanomedicine

DK Zhao, J Liang, XY Huang, S Shen… - Wiley Interdisciplinary …, 2023 - Wiley Online Library
The past decades have witnessed the rapid development and widespread application of
nanomedicines in cancer treatment; however, the clinical translation of experimental …

Challenges and opportunities in delivering oral peptides and proteins

H Peng, J Wang, J Chen, Y Peng, X Wang… - Expert opinion on …, 2023 - Taylor & Francis
Introduction Rapid advances in bioengineering enable the use of complex proteins as
therapeutic agents to treat diseases. Compared with conventional small molecule drugs …

[HTML][HTML] When albumin meets liposomes: a feasible drug carrier for biomedical applications

K Taguchi, Y Okamoto, K Matsumoto, M Otagiri… - Pharmaceuticals, 2021 - mdpi.com
Albumin, the most abundant protein in plasma, possesses some inherent beneficial
structural and physiological characteristics that make it suitable for use as a drug delivery …

[HTML][HTML] Treg-targeted efficient-inducible platform for collagen-induced arthritis treatment

L Wang, Y Wang, C Liu, J He, X He, X Zhang, C Zhu… - Materials Today Bio, 2023 - Elsevier
Regulatory T cells (Tregs) display great promise in rheumatoid arthritis (RA) therapy.
However, their low number and differentiation rate limit their further application in the clinics …

Synthesis and characterization of surface-modified ultrafine titanium dioxide nanoparticles with an antioxidant functionalized biopolymer as a therapeutic agent …

EJ Diana, TV Mathew - Colloids and Surfaces B: Biointerfaces, 2022 - Elsevier
Surface modified biodegradable protein-based nanoparticles have great potential in
pharmaceutical applications. In the present study, we discuss the surface engineering of …